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Purpose: Visceral fat (VF) is closely associated with many metabolic risk factors 
and is also known to be a strong predictive factor for severe metabolic complications 
in adults. But there are only a few studies concerning the association of VF and risk 
factors for metabolic syndrome (MS) in children and adolescents. In our study, we 
emphasized the association of VF [measured by VF computed tomography (VFCT)] 
and risk factors for metabolic syndrome in children and adolescents. Materials and 
Methods: The subjects were outpatients aged 6 to 18 years who underwent VFCT 
in the family medicine of The Catholic University of Korea from January 2005 to 
August 2009. There were 82 patients in total (42 children, 40 adolescents). Height, 
weight, blood pressure (BP), blood tests, body composition analysis and VF were 
measured. The three groups were also classified by metabolic score. Results: In chil-
dren, only high density lipoprotein cholesterol (HDL-C) showed a statistically signif-
icant difference, while in adolescents, triglyceride, HDL-C, BP, body mass index 
(BMI), waist circumference (WC) and VFA showed statistically significant differ-
ences. In terms of VFA, fasting glucose, BP, BMI, basal metabolic rate (BMR) and 
WC showed statistically significant differences. BMI showed a statistically signifi-
cant difference in terms of BP, BMR, WC, VFA and HDL-C. Conclusion: There is a 
need to acknowledge the statistically significant associations of VF and risk factors 
for MS in children and adolescents. Screening tests for BP, cholesterol, fasting glu-
cose and WC should be given in clinics for children and adolescents so that MS can 
be detected and its risk factors treated early. 
Key Words: Children, adolescents, metabolic syndrome, visceral fat 
INTRODUCTION
In recent years, the prevalence of overweight or obese children and adolescents 
has been rapidly increasing.1 The rate of increase exceeds even that of adults.2 A 
10-fold increase (1.7→17.9%) for boys and a 4.5-fold increase (2.4→10.9%) for 
girls was reported in Seoul between 1979 and 2002.3 Obese children and adoles-
cents are more likely to develop into obese adults,4,5 and also have a high risk of Jeong-Hyeon Kwon, et al.
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cm respectively. Waist circumference (WC) was measured 
while the patient exhaled slightly, with no pressure applied, 
and then we measured the area between the lowest rib and 
the upper part of the iliac crest. BP was measured according 
to the recommendations from the American Heart Associa-
tion (AHA). The patients relaxed for more than 10 minutes 
and while they were sitting we measured twice, each mea-
surement 5 minutes apart. The final BP was the mean value 
of these two measurements. The patients did not eat any-
thing for 12 hours prior to the blood tests. After withdraw-
ing 15 mL of blood, it was sent to the laboratory for fasting 
glucose, total cholesterol, triglyceride, high density lipopro-
tein cholesterol (HDL-C) etc. Body composition analysis 
was made using Biospace Corp. In Body 4.0 body fat ana-
lyzer. VFCT was referred to the radiologist. The lower ab-
domen of each subject was covered with lead protectors in 
order to protect them from radioactive exposure. VFCT 
was done around the 4th lumbar vertebra area where subcu-
taneous and visceral fat were measured. 
Definition
The definition of the MS in children and adolescents was 
made by the corrected criteria of the NCEP ATP III. If three 
or more criteria were satisfied, we considered it MS in chil-
dren and adolescents (Table 1).18
Statistical analysis 
According to NCEP ATP III criteria, the MS score was clas-
sified as 0-1, 2-3 and 4-5. We compared fasting blood glu-
cose, total blood cholesterol, blood triglyceride, blood HDL-
C, systolic and diastolic BP, basal metabolic rate (BMR), 
WC, subcutaneous fat, VF and total fat area. All results were 
denoted as a mean ± S.D. A t-test for independent samples 
was used to assess the differences between two groups. The 
three groups were classified by MS score and analyzed by an 
ANOVA test. Visceral fat area (VFA), BMI and other risk 
factors were analyzed by the Pearson correlation. Statistical 
analysis of the data was done by Statistical Package for So-
cial Science (SPSS) 15.0 for Windows (SPSS Inc, Chicago, 
IL, USA). We considered a p value of less than 0.05 to be 
statistically significant.
RESULTS
Patients and baseline characteristics
There were 82 subjects in total (children: 42, adolescents: 
affliction with associated metabolic complications as they 
grow to adults. For instance, Type II diabetes mellitus, hy-
pertension, dyslipidemia and atherosclerosis can develop.6-8 
This fact causes excessive personal and social cost, and is 
the reason why more aggressive intervention and counter-
measures must be implemented to control metabolic syn-
drome (MS) in Korean children and adolescents.9,10 Until 
now, there has been insufficient information concerning di-
agnostic criteria for MS in children and adolescents. In chil-
dren and adolescents, physical as well as physiological 
changes are taking place. Blood pressure (BP), body mass 
index (BMI) and blood cholesterol levels vary according to 
age, which makes it hard to set a cut off value for diagnos-
tic criteria. Fortunately, in 2007, the International Diabetes 
Federation reported the diagnostic criteria for MS in chil-
dren and adolescents,11 and this criterion is being used 
along with the variation for children and adolescents of Na-
tional Cholesterol Education Program (NCEP) Adult Treat-
ment Panel (ATP) III criteria. VF is closely associated with 
many metabolic risk factors and is also known to be a strong 
predictive factor of severe metabolic complications in 
adults.12-17 However, few studies have been done concern-
ing the association of VF and risk factors for MS in chil-
dren and adolescents. In our study, we emphasized the as-
sociation between VF [measured by VF computed tomo-
graphy (VFCT)] and risk factors for MS in children and 
adolescents.
MATERIALS AND METHODS
Materials
All subjects gave written informed consent before taking 
part in this study. The subjects were outpatients, aged 6 to 
18 years, who underwent VFCT in the family medicine 
clinic of The Catholic University of Korea located in Seoul 
and Gyeonggi province from January 2005 to August 2009. 
There were 82 patients in total (42 children, 40 adoles-
cents). Height, weight, BP, blood tests, body composition 
analysis and VF were measured. The three groups of chil-
dren and adolescents were then classified by metabolic 
scores. The study was approved by The Catholic University 
of Korea’s ethics committee.
Methods
Height and weight were measured with the patient wearing 
light clothes or only a gown. We measured up to 0.1 kg, 0.1 Visceral Fat
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(boys) and 1214.0 ± 309.4 kcal (girls) in children, and 1868.3 
± 446.2 kcal (boys) and 1505.1 ± 312.8 kcal (girls) in adoles-
cents. WC was 90.9 ± 6.6 cm (boys) and 80.7 ± 10.5 cm 
(girls) in children, and 97.5 ± 7.9 cm (boys) and 94.1 ± 9.5 
cm (girls) in adolescents. VFA was 75.2 ± 26.0 cm2 (boys) 
and 61.9 ± 15.2 cm2 (girls) in children, and 87.6 ± 30.3 cm2 
(boys) and 89.4 ± 42.5 cm2 (girls) in adolescents. BMI was 
27.1 ± 3.4 (kg/m2) (boys) and 26.1 ± 5.8 (kg/m2) (girls) in 
children, and 31.4 ± 4.5 (kg/m2) (boys) and 32.4 ± 7.7 (kg/
m2) (girls) in adolescents. Percentage body fat (%BF) was 
38.6 ± 4.7% (boys) and 37.0 ± 4.9% (girls) in children, and 
33.1 ± 5.3% (boys) and 42.3 ± 7.7% (girls) in adolescents. 
Subcutaneous fat area (SCFA) was 213.6 ± 67.0 cm2 (boys) 
and 197.4 ± 100.8 cm2 (girls) in children, and 272.9 ± 84.6 
cm2 (boys) and 336.1 ± 144.5 cm2 (girls) in adolescents. The 
40). The mean age of the children was 10.1 ± 1.5 yrs for boys 
and 9.1 ± 1.8 yrs for girls. The mean age of the adolescents 
was 15.5 ± 1.6 yrs for boys and 15.5 ± 1.7 yrs for girls. Fast-
ing blood glucose (FBG) was 96.1 ± 9.8 mg/dL (boys) and 
93.9 ± 8.7 mg/dL (girls) in children, and 103.9 ± 9.1 mg/dL 
(boys) and 95.3 ± 17.0 mg/dL (girls) in adolescents. Blood 
triglyceride levels were 137.7 ± 66.5 mg/dL (boys) and 152.7 
± 86.6 mg/dL (girls) in children, and 152.6 ± 51.6 mg/dL 
(boys) and 135.9 ± 60.6 mg/dL (girls) in adolescents. Blood 
HDL-C was 45.6 ± 12.6 mg/dL (boys) and 43.4 ± 6.8 mg/dL 
(girls) in children, and 40.0 ± 8.5 mg/dL (boys) and 43.5 ± 
9.0 mg/dL (girls) in adolescents. Systolic BP was 120.9 ± 
11.7 mmHg (boys) and 116.5 ± 11.3 mmHg (girls) in chil-
dren, and 138.6 ± 10.4 mmHg (boys) and 128.1 ± 15.9 
mmHg (girls) in adolescents. BMR was 1211.3 ± 185.2 kcal 
Table 1. Modified Criteria of Metabolic Syndrome in Children and Adolescents
Criteria
Adults & Adolescents
Children
(NCEP ATP III) 
Triglyceride (mg/dL)   ≥ 150   ≥ 110
HDL-C (mg/dL)
    Boys < 40  ≤ 40
    Girls                                                         < 50 ≤ 40
Fasting glucose (mg/dL)   ≥ 110   ≥ 110
Waist circumference (cm)
   Boys   ≥ 102 ≥ 90th% for age, sex
    Girls  ≥ 88 ≥ 90th% for age, sex
Blood pressure (mmHg)        ≥ 130/85 ≥ 90th% for age, sex, height
NCEP ATP III, National Cholesterol Educational Program Adult Treatment Panel III; HDL-C, high density lipoprotein cholesterol.
Table 2. Characteristics of the Study Population (n = 82)
Boys (n = 42) Girls (n = 40)
Children 
(n = 27)
Adolescents 
(n = 15)
Children 
(n = 15)
Adolescents 
(n = 25)
Age (yrs) 10.1 ± 1.5 15.5 ± 1.6   9.1 ± 1.8 15.5 ± 1.7
Fasting glucose (mg/dL) 96.1 ± 9.8 103.9 ± 9.1 93.9 ± 8.7 95.3 ± 17.0
Triglyceride (mg/dL) 137.7 ± 66.5 152.6 ± 51.6 152.7 ± 86.6 135.9 ± 60.6
HDL-C (mg/dL)   45.6 ± 12.6 40.0 ± 8.5 43.4 ± 6.8 43.5 ± 9.0
Systolic BP (mmHg) 120.9 ± 11.7 138.6 ± 10.4 116.5 ± 11.3 128.1 ± 15.9
Diastolic BP (mmHg) 73.4 ± 8.4 77.1 ± 6.8   69.5 ± 10.0 77.6 ± 10.0
BMI (kg/m
2) 27.1 ± 3.4 31.4 ± 4.5 26.1 ± 5.8 32.4 ± 7.7
%Body fat 38.6 ± 4.7 33.1 ± 5.3 37.0 ± 4.9 42.3 ± 7.7
BMR (kcal) 1211.3 ± 185.2 1868.3 ± 446.2 1214.0 ± 309.4 1505.1 ± 312.8
Waist circumference (cm) 90.9 ± 6.6 97.5 ± 7.9   80.7 ± 10.5 94.1 ± 9.5
Visceral fat area (cm
2)   75.2 ± 26.0 87.6 ± 30.8   61.9 ± 15.2 89.4 ± 42.5
Subcutaneous fat area (cm
2) 213.6 ± 67.0 272.9 ± 84.6   197.4 ± 100.8 336.1 ± 144.5
Total abdominal fat area (cm
2) 292.2 ± 86.4 376.0 ± 84.6   263.0 ± 109.7 441.9 ± 198.8
BP, blood pressure; HDL-C, high density lipoprotein cholesterol; BMI, body mass index; BMR, basal metabolic rate.Jeong-Hyeon Kwon, et al.
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total abdominal fat area (TAFA) was 292.2 ± 86.4 cm2 
(boys) and 263.0 ± 109.7 cm2 (girls) in children, and 
376.0 ± 84.6 cm2 (boys) and 441.9 ± 198.8 cm2 (girls) 
in adolescents (Table 2).
Comparisons between groups by MS risk factors
In our study we classified the 82 subjects according to 
the NCEP ATP III criteria and the scores for MS were 
classified using 0-1, 2-3 and 4-5. 
1) FBG, %BF, BMR, SCFA and TAFA: these factors 
did not show statistically significant differences between 
each group in children and adolescents (p < 0.05).
2) Blood triglyceride, systolic and diastolic BP, BMI, 
WC and VFA: these factors did not show statistically 
significant differences between groups in children, but 
did show statistically significant differences in adoles-
cents (p < 0.05).
3) Blood HDL-C: this factor showed statistically 
significant differences between groups in both children 
and adolescents. 
Correlations between VFA, BMI by metabolic risk 
factor 
1) BMI: At a p value of 0.01, there were statistically sig-
nificant differences in systolic and diastolic BP, %BF, 
BMR, WC, VFA, SCFA and TAFA. At a p value of 
0.05, there were statistically significant differences in 
HDL-C.
2) VFA: At the p value of 0.01 there were a statisti-
cally significant differences in fasting glucose, systolic 
and diastolic BP, BMI, %BF, BMR, WC, SCFA and 
TAFA. At the p value of 0.05, there were statistically 
significant differences in HDL-C.
DISCUSSION
It is known that obesity in children and adolescents is 
related to high prevalence of metabolic complica-
tions.19-21 In 2004 Chang, et al.22 reported that the preva-
lence of MS in children and adolescents was 37.5% 
(boys: 38.7%, girls: 35.2%) by the corrected criteria of 
NCEP ATP III. Considering that the prevalence of obe-
sity in children and adolescents in the United States is 
28.7%, we believe the time, method and criteria of the 
study is critical in Korea.23,24
There have not been many studies concerning the 
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and HDL-C, while BMI was related to systolic and diastol-
ic BP, %BF, BMR, WC, VFA, SCFA, TAFA and HDL-C. 
The aforementioned associations between VF and risk fac-
tors for MS suggest the need for abdominal fat measure-
ment.28 But there are some groups who oppose VFCT due 
to radioactive exposure.
Our study had two important limitations. First of all, di-
agnosis of MS in children and adolescents is not standard-
ized, because children and adolescents continue to grow, 
making it difficult to set a normal value and to have long-
term follow-up. Also, there is little interest in MS in chil-
dren and adolescents worldwide, including in the Republic 
of Korea. Second, we enrolled only a total of 82 subjects 
because it was difficult to find subjects due to fear of radio-
active exposure from VFCT. Safety and verification of ra-
dioactive exposure should be studied. 
According to AHA, as the prevalence of MS increases in 
children and adolescents, severe metabolic complications 
also increase. In clinics for children and adolescents, screen-
ing tests for BP, serum cholesterol, serum glucose and ab-
dominal circumference should be undertaken. Thus, early de-
tection and follow-up of risk factors for MS can be possible. 
There is a strong need to set a cut-off value for diagnostic cri-
teria of MS risk factors in children and adolescents. 
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had the same results as other studies. In Korean studies, the 
risk of cardiovascular disease was higher when more than 
one metabolic risk factor was involved.27 In our study, we 
compared the associations between VF (measured by VFCT) 
and BMI between risk factors for MS by groups. VFA was 
statistically significant in relation to fasting glucose, systol-
ic and diastolic BP, BMI, %BF, BMR, WC, SCFA, TAFA 
Table 4. Correlation between Body Mass Index, Visceral Fat Area and Obesity Related Factors
Mean ± SD
BMI VFA
Pearson correlation p value Pearson correlation p value
Fasting glucose (mg/dL)   96.9 ± 12.5 - 0.075 0.501   0.310
† 0.005
Triglyceride (mg/dL) 142.6 ± 65.8  0.111 0.322  0.187 0.093
HDL-C (mg/dL) 43.6 ± 9.9  - 0.230* 0.038  - 0.276* 0.012
Systolic BP (mmHg) 125.5 ± 14.7   0.442
† 0.000   0.335
† 0.002
Diastolic BP (mmHg) 74.7 ± 9.3   0.329
† 0.003   0.361
† 0.001
BMI (kg/m
2) 29.3 ± 6.1 1 -   0.618
† 0.000
%Body fat 38.4 ± 6.6   0.536
† 0.000   0.372
† 0.001
BMR (kcal) 1421.5 ± 390.9   0.616
† 0.000   0.516
† 0.000
Waist circumference (cm)   91.2 ± 10.1   0.616
† 0.000   0.471
† 0.000
Visceral fat area (cm
2)   79.4 ± 32.6   0.618
† 0.000 1 -
Subcutaneous fat area (cm
2)   258.9 ± 117.8   0.736
† 0.000   0.574
† 0.000
Total abdominal fat area (cm
2)   347.8 ± 155.3   0.760
† 0.000   0.722
† 0.000
BMI, body mass index; VFA, visceral fat area; HDL-C, high density lipoprotein cholesterol; BP, blood pressure; BMR, basal metabolic rate.
*Correlation is significant at the 0.05 level.
†Correlation is significant at the 0.01 level.Jeong-Hyeon Kwon, et al.
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